Clinical trials for Cancer in United States

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Study ID: NCT06624839

Sponsor

University of Maryland, Baltimore

Decision Making for Urinary Diversion in Patients With Bladder Cancer

Study ID: NCT05111639

Sponsor

University of Colorado, Denver

Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma

Study ID: NCT05618366

Sponsor

Weill Medical College of Cornell University

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Study ID: NCT06483139

Sponsor

Brigham and Women's Hospital

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Study ID: NCT05681039

Sponsor

M.D. Anderson Cancer Center

ArtemiCoffee in Patients With Rising PSA

Study ID: NCT05478239

Sponsor

Zin W Myint

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

Study ID: NCT02610439

Sponsor

National Cancer Institute (NCI)

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Study ID: NCT06236139

Sponsor

Fred Hutchinson Cancer Center

Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy

Study ID: NCT04272086

Sponsor

Icahn School of Medicine at Mount Sinai

An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

Study ID: NCT05364086

Sponsor

University of Rochester NCORP Research Base